• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 3. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 4. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

Comprehensive Guide to Ethyl (S)-2-(Benzyloxy)propionate (CAS No. 54783-72-1): Properties, Applications, and Market Insights

Ethyl (S)-2-(Benzyloxy)propionate (CAS No. 54783-72-1) is a chiral ester compound widely recognized for its versatility in organic synthesis and pharmaceutical applications. This optically active molecule features a benzyloxy group and an ethyl propionate moiety, making it a valuable intermediate in asymmetric synthesis. With the growing demand for enantiomerically pure compounds in drug development, (S)-2-(Benzyloxy)propionic acid ethyl ester has gained significant attention from researchers and manufacturers alike.

The compound's molecular formula is C₁₂H₁₆O₃, and it typically appears as a colorless to pale yellow liquid at room temperature. Its chiral purity (>98% ee) makes it particularly useful for producing active pharmaceutical ingredients (APIs) with specific stereochemical requirements. Recent studies highlight its role in synthesizing beta-lactam antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs), aligning with current pharmaceutical trends toward targeted therapies.

In the flavor and fragrance industry, Ethyl (S)-2-Benzyloxypropanoate serves as a precursor for creating fruity esters with enhanced olfactory properties. The compound's ability to impart berry-like and tropical fruit notes has made it valuable for developing new food additives and perfumery components. This application has become particularly relevant with the rising consumer demand for natural-identical flavor compounds in the food and beverage sector.

The synthesis of 54783-72-1 typically involves asymmetric hydrogenation or enzymatic resolution methods, reflecting the industry's shift toward green chemistry approaches. Manufacturers are increasingly adopting biocatalytic processes to produce this compound, responding to the pharmaceutical sector's need for sustainable and cost-effective chiral building blocks. These production innovations address frequently searched topics like "environmentally friendly chiral synthesis" and "biocatalysis in pharmaceutical manufacturing."

Market analysis shows growing demand for Ethyl (S)-2-(Benzyloxy)propionate across North America, Europe, and Asia-Pacific regions, driven by expanding pharmaceutical R&D activities. The compound's price stability and reliable supply chain have made it a preferred choice for contract manufacturing organizations (CMOs) specializing in chiral intermediates. Industry reports suggest this market segment will grow at a CAGR of 5-7% through 2028, paralleling the expansion of the global chiral chemicals market.

Quality control standards for CAS 54783-72-1 typically require HPLC purity ≥98% and enantiomeric excess ≥98%, with strict limits on residual solvents. These specifications cater to pharmaceutical GMP requirements, making the compound suitable for API synthesis. Analytical methods like chiral GC and polarimetry are commonly employed for quality verification, topics frequently searched by quality assurance professionals in the fine chemicals industry.

Recent patent literature reveals novel applications of (S)-Ethyl 2-benzyloxypropionate in polymer chemistry, particularly for creating chiral polymeric materials with potential optoelectronic applications. This development aligns with growing interest in functional materials for organic electronics and displays. Researchers are investigating its use as a monomer for synthesizing polymers with controlled helicity, addressing the search trend for "chiral polymers in material science."

Storage and handling recommendations for Ethyl (S)-2-(Benzyloxy)propionate include protection from moisture and oxidation, typically under inert atmosphere at 2-8°C. While not classified as hazardous under standard conditions, proper laboratory practices should be followed during handling. These operational considerations respond to common queries about "chiral ester storage conditions" and "handling sensitive synthetic intermediates."

The compound's structure-activity relationship has been extensively studied for various biological targets, particularly in the context of prodrug development. Its benzyl-protected hydroxyl group and ester functionality make it a versatile scaffold for medicinal chemistry applications. This characteristic explains its frequent appearance in recent scientific literature addressing "prodrug design strategies" and "esterase-sensitive drug delivery systems."

Looking ahead, technological advancements in asymmetric synthesis and purification methods are expected to further improve the commercial viability of 54783-72-1. The integration of continuous flow chemistry and membrane separation technologies may address current challenges in large-scale production. These innovations correspond to industry searches for "continuous manufacturing of chiral compounds" and "membrane applications in fine chemical purification."

• 56777-24-3(benzyl (2S)-2-hydroxypropanoate)
• 100836-85-9((2R)-2-(benzyloxy)propanoic acid)
• 115458-99-6(Methyl (R)-2-(Benzyloxy)propionate)
• 33106-32-0((2S)-2-(benzyloxy)propanoic acid)
• 2051-96-9(BENZYL 2-HYDROXYPROPIONATE)
• 2040-44-0(rac Ethyl 2-(Benzyloxy)propionate)
• 6625-78-1(2-(benzyloxy)propanoic acid)
• 1363165-96-1(Benzyl 2-Methoxy-2-methylpropionate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)